New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 17, 2014
09:15 EDTICPT, FPRX, GMCR, YHOO, HNR, LO, WPX, HTZ, JASO, BMY, VRSN, SINAOn The Fly: Pre-market Movers
UP AFTER EARNINGS: JA Solar (JASO), up 16%. ALSO HIGHER: Five Prime (FPRX), up 13% after signing collaborative agreement with Bristol-Myers (BMY)... SINA (SINA), up 9% after files preliminary prospectus to raise up to $500M in U.S. IPO of Weibo unit... Hertz (HTZ), up 7.7% after Financial Times says the company is nearing a spin-off of its construction equipment rental business... Lorillard (LO), up 2.5% following upgrade at Goldman... Keurig Green Mountain (GMCR), up 3.7% after being selected to replace WPX Energy (WPX) in S&P 500 as of March 21 close... Yahoo (YHOO), up 4.1% after Alibaba announces plan to begin U.S. IPO process... LOWER: Intercept (ICPT), down 0.6% after disclosing two serious adverse events in Phase 2 FLINT trial... Harvest Natural (HNR), down 10% after earnings report. VeriSign (VRSN), down 5% after the National Telecommunications and Information Administration said it intends to transition key Internet domain name functions.
News For YHOO;SINA;HTZ;GMCR;VRSN;WPX;FPRX;BMY;LO;ICPT;JASO;HNR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
December 17, 2014
13:44 EDTYHOOYahoo holders continue push for AOL merger, NY Times reports
Subscribe for More Information
06:36 EDTJASOU.S. announces tariffs on Chinese, Taiwanese solar companies, NY Times says
The U.S. announced that it would impose tariffs of 26.7%-78.4% on the imports of most Chinese made solar panels, and tariffs of 11.45%-27.5% on solar cells made in Taiwan, according to The New York Times. Duties of 27.6%-50% will be imposed on modules made in China, the newspaper quoted the Commerce Department as saying. American officials still hope that they can reach a settlement with the Chinese on solar trade issues, the newspaper stated. Publicly traded companies in the space include Canadian Solar (CSIQ), First Solar (FSLR), JA Solar (JASO), SunPower (SPWR), Trina Solar (TSL) and Yingli Green Energy (YGE). Reference Link
December 16, 2014
09:23 EDTWPXWPX Energy upgraded to Focus List from Outperform at Howard Weil
08:47 EDTBMYHemispherx Ampligen provides anti-tumor activity
Subscribe for More Information
December 15, 2014
08:58 EDTICPTIntercept reinstated with a Buy at BofA/Merrill
Subscribe for More Information
06:38 EDTGMCRKeurig Green Mountain transferring coffee buying to Switzerland, Reuters says
Keurig Green Mountain is moving a majority of its U.S. coffee buying operations to Switzerland, emulating its competitors, according to Reuters. The move will make the company "a global beverage player," Reuters quoted a Green Mountain spokeswoman as saying. Reference Link
06:27 EDTLOLorillard, Reynolds investors to vote on merger on January 28, WSJ reports
Reynolds American (RAI) and Lorillard (LO) shareholders will vote on the proposed $25B merger on January 28, The Wall Street Journal reports. The FTC is continuing its antitrust review on the deal, and a ruling is expected in 1H15. Reference Link
December 11, 2014
10:17 EDTYHOOCiti upbeat on Google in face of pending Apple decision on Safari
Subscribe for More Information
09:00 EDTGMCRKeurig Green Mountain announces expanded agreement with Caribou Coffee
Subscribe for More Information
08:57 EDTICPTLeerink major pharma & biotech analysts hold analyst/industry conference call
Subscribe for More Information
08:09 EDTYHOOGoogle shares pricing in loss of Apple search deal, says Citigroup
Subscribe for More Information
December 10, 2014
12:09 EDTSINAYouku Tudou rises slightly in down market after Credit Suisse upgrade
Subscribe for More Information
11:41 EDTGMCRGreen Mountain Coffee December calls active
Green Mountain Coffee December weekly 140 calls are active on total call volume of 2,200 contracts, compared to its open interest of 395 contracts. December weekly call option implied volatility is at 57, December is at 37, January is at 32, March is at 33; compared to its 26-week average of 42 according to Track Data. Active call volume suggests traders taking positions for large near term price movement
08:03 EDTHTZHertz expands across Europe with more than 80 branches in 2014
Subscribe for More Information
06:08 EDTBMYBristol-Myers partners with Ono Pharma and Kyowa Hakko Kirin for oncology trial
Subscribe for More Information
December 9, 2014
16:35 EDTBMYBristol-Myers raises dividend to 37c per share from 36c per share
Subscribe for More Information
08:25 EDTBMYBristol-Myers data positive, says BMO Capital
Subscribe for More Information
December 8, 2014
13:32 EDTBMYPfizer, Bristol-Myers announce results of human study on Eliquis
Bristol-Myers Squibb Company (BMY) and Pfizer (PFE) announced results of the first human study evaluating the reversal of the anticoagulant effect of Eliquis by 4-factor prothrombin complex concentrates in healthy subjects. The study results demonstrated that both PCCs, Sanquin’s Cofact and CSL Behring’s Beriplex P/N reversed the steady-state pharmacodynamic effects of Eliquis in several coagulation assessments, including endogenous thrombin potential. The full data will be presented today during the Antithrombotic Therapy: Anticoagulant Therapy session at the 56th annual meeting of the American Society of Hematology in San Francisco, CA. The study was an open label, randomized, placebo-controlled, three-period crossover study in 15 healthy, adult subjects. Within each period, subjects received Eliquis 10 mg twice daily. On day four, three hours after Eliquis administration, subjects received a 30-minute infusion of 4-factor PCCs, either 50 IU/kg Cofact or Beriplex P/N, or an equivalent volume of saline solution. The effect of Cofact and Beriplex P/N on the pharmacodynamics of Eliquis was based upon changes in endogenous thrombin potential, a measure of thrombin-mediated coagulation. Treatment periods were separated by an 11-day washout, after which the alternate treatment was administered. In this study, no serious adverse events, bleeding-related events or signs of thrombosis were reported with Eliquis administration with or without PCC treatment. Overall, these data demonstrate that Cofact and Beriplex P/N reversed the steady-state pharmacodynamic effects of Eliquis as measured by ETP and support further evaluation of PCCs in the management of patients treated with Eliquis who require reversal of its anticoagulant effect.
09:01 EDTJASOJA Solar supplies 100MW of modules to solar farm in Pakistan
Subscribe for More Information
05:53 EDTBMYStocks with implied volatility movement; BSX BMY
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use